Drug · DIN 02432986
NUWIQ
ANTIHEMOPHILIC FACTOR (RECOMBINANT, B-DOMAIN DELETED). KIT CONTAINING A) SINGLE-USE VIAL AND B) DILUENT (2.5 ML PREFILLED SYRINGE)
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since July 24, 2024; first marketed December 22, 2015.
- Drug Identification Number (DIN)
- 02432986
- Company (DIN owner)
- Octapharma Pharmazeutika Produktionsges M B HVienna, Vienne, Austria
- Schedule
- Schedule D
- Dosage form
- Kit; Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Coagulation factor viii B02BD02
- Class
- Human
- Record last updated
- September 21, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SIMOCTOCOG ALFA | 1000 UNIT | VIAL |
| WATER | 2.5 ML | SYR |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 23, 2014: NOC 16246New Drug Submission (NDS)
Other DINs named NUWIQ
- DIN 02432951 · Dormant
- DIN 02432978 · Dormant
- DIN 02432994 · Dormant
- DIN 02474042 · Approved
- DIN 02474050 · Dormant
- DIN 02474069 · Dormant
- DIN 02534169 · Approved